Skip to content

PalliSupport, a transitional care pathway for elderly patients at the end of life

PalliSupport, a transitional care pathway for elderly patients at the end of life - PalliSupport

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46089
Enrollment
600
Registered
2018-10-26
Start date
2019-01-07
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kwetsbaarheid en/of ongeneeslijke aandoening met een levensverwachting van minder dan een jaar Life threatening disease and frailty

Interventions

The intervention consists of a transitional care pathway that starts during an acute hospitalisation. The intervention consists of timely identification with the Surprise Question and SPICT criteria
a copy will also be sent to the primary care physicians and home care services. After discharge the patient is followed up by the palliative care team and discussed in the MDT until this is deemed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Age (*65 years); 2) Acutely admitted for *48 hours to the departments of internal medicine, geriatrics, cardiology, pulmonary disease, gastroenterology or oncology; 3) Positive SPICT* criteria*: a hospital admission in six months prior to admission, functional status decline and weight loss (65-79 years: two or more positive criteria, >80 years: 1 or more positive criteria); 4) Ability to read and speak the Dutch language;

Exclusion criteria

Exclusion criteria: Patients who are not able to answer questionnaires due to severe cognitive impairment (MMSE

Design outcomes

Primary

MeasureTime frame
The primary outcome is the occurrence of (at least one) unplanned hospitalisation in the six months after discharge.

Secondary

MeasureTime frame
Secondary outcomes are dying at the place of patient*s preference. Furthermore, the quality of life, symptom burden, palliative outcomes, caregivers* burden and health care utilisation will be assessed.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)